Detalhe da pesquisa
1.
A review of economic issues for gene-targeted therapies: Value, affordability, and access.
Am J Med Genet C Semin Med Genet
; 193(1): 64-76, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854952
2.
Genomic medicine year in review: 2023.
Am J Hum Genet
; 110(12): 1992-1995, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38065071
3.
Genomic Medicine Year in Review: 2022.
Am J Hum Genet
; 109(12): 2101-2104, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459977
4.
Opportunities, resources, and techniques for implementing genomics in clinical care.
Lancet
; 394(10197): 511-520, 2019 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395439
5.
Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
Value Health
; 23(5): 540-550, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389218
6.
Genomic medicine year in review: 2021.
Am J Hum Genet
; 108(12): 2210-2214, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861172
7.
Genomic Medicine Year in Review: 2020.
Am J Hum Genet
; 107(6): 1007-1010, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275910
8.
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.
Value Health
; 21(9): 1033-1042, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224106
9.
Genomic Medicine Year in Review: 2019.
Am J Hum Genet
; 105(6): 1072-1075, 2019 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027834
10.
Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.
Genet Med
; 19(5): 559-567, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27657682
11.
Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research.
Genet Med
; 19(10): 1081-1091, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28406488
12.
Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
J Natl Compr Canc Netw
; 15(2): 219-228, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188191
13.
Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.
Value Health
; 20(1): 40-46, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28212967
14.
EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.
Int J Technol Assess Health Care
; 33(4): 534-540, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29065945
15.
Economic opportunities and challenges for pharmacogenomics.
Annu Rev Pharmacol Toxicol
; 50: 423-37, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20055709
16.
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.
Genet Med
; 14(7): 656-62, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22481130
17.
Prioritization in comparative effectiveness research: the CANCERGEN Experience.
Med Care
; 50(5): 388-93, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22274803
18.
Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access.
Health Aff (Millwood)
; 41(3): 383-389, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254936
19.
Comparative effectiveness research and demonstrating clinical utility for molecular diagnostic tests.
Clin Chem
; 61(1): 142-4, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25274556
20.
Genetic testing and employer-sponsored wellness programs: An overview of current vendors, products, and practices.
Mol Genet Genomic Med
; 8(10): e1414, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715662